Paul Strumph, Rick Turner and Associates at Quintiles introduce a new Commentary Series entitled Lessons Learned in Developing Cardiovascular and Metabolic Drugs, that will appear in each issue of this journal.

Andrew Catton of Miller Insurance Services LLP explains why product liability insurance is becoming more restrictive for many pharmaceutical, biotech and medical equipment companies, and what organisations can do to maintain affordable cover.